Bio Plus Co., Ltd
KOE: 099430.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Hyun-Kyu Jung
- Employees
- 102
- Headquarters
- Seongnam-si, United States
- IPO year
- 2021
- Market cap
- ₩350.8B
- Website
- https://www.ubioplus.co.kr
Loading 099430…
Loading profile data…Frequently asked questions about 099430
What does Bio Plus Co., Ltd (099430.KQ) do?
Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a s...
Where does 099430.KQ trade?
Bio Plus Co., Ltd (099430.KQ) trades on the KOSDAQ.
What sector is 099430.KQ in?
Bio Plus Co., Ltd (099430.KQ) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Bio Plus Co., Ltd?
Hyun-Kyu Jung is the chief executive officer of Bio Plus Co., Ltd (099430.KQ).
Where is Bio Plus Co., Ltd headquartered?
Bio Plus Co., Ltd is headquartered in United States.
Does 099430.KQ pay a dividend?
Yes — Bio Plus Co., Ltd (099430.KQ) paid a trailing twelve-month dividend of KRW 50.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 099430.KQ go public?
Bio Plus Co., Ltd (099430.KQ) completed its initial public offering in 2021.